Jewish General Hospital ( Site 0105)

Montreal, Quebec H3T 1E2

0 studies enrolling now · 2 studies all time

What they study most

Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Non-small Cell Lung Cancer

Studies at this site

• Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003) — Stopped early
• Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789) — Completed